Visa Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Visa Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1321
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:189
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Visa Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Visa Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Visa Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Visa Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Visa Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Visa Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Visa Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Visa Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Visa Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 6
LIST OF TABLES 8
LIST OF FIGURES 8
TARGETS AND PARTNERS 9
MERGERS & ACQUISITIONS 10
Mergers and Acquisitions – Overview 10
Mergers and Acquisitions – Deal reports 11
CORPORATE VENTURING 48
Corporate Venturing – Overview 48
Corporate Venturing – Deal reports 49
PARTNERSHIP 103
Partnership – Overview 103
Partnership – Deal reports 104
CAPITAL RAISING 145
Capital Raising – Overview 145
Capital Raising – Deal reports 146
DIVESTMENTS 152
Divestments – Overview 152
Divestments – Deal reports 153
PRIVATE EQUITY & OWNERSHIP 171
Private Equity and Ownership – Overview 171
Private Equity and Ownership – Deal reports 172
APPENDIX 179
Contact Us 179
About MarketLine Financial Deals Database 179
Deal Definition and Methodology 181
About MarketLine 188

List of Tables
Table 1: Visa Inc. M&A volume and value trend (2014-YTD2018)
Table 2: Visa Inc. M&A activity by geography (2014-YTD2018)
Table 3: Visa Inc. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Visa Inc. corporate venturing by geography (2014-YTD2018)
Table 5: Visa Inc. partnership volume and value trend (2014-YTD2018)
Table 6: Visa Inc. partnership trend by key deal type (2014-YTD2018)
Table 7: Visa Inc. capital raising volume and value trend (2014-YTD2018)
Table 8: Visa Inc. capital raising by deal type (2014-YTD2018)
Table 9: Visa Inc. divestments volume and value trend (2014-YTD2018)
Table 10: Visa Inc. divestments activity by geography (2014-YTD2018)
Table 11: Visa Inc. private equity and ownership volume and value trend (2014-YTD2018)
Table 12: Visa Inc. private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Visa Inc. M&A volume and value trend (2014-YTD2018)
Figure 2: Visa Inc. M&A activity by geography (2014-YTD2018)
Figure 3: Visa Inc. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Visa Inc. corporate venturing by geography (2014-YTD2018)
Figure 5: Visa Inc. partnership volume and value trend (2014-YTD2018)
Figure 6: Visa Inc. partnership trend by key deal type (2014-YTD2018)
Figure 7: Visa Inc. capital raising volume and value trend (2014-YTD2018)
Figure 8: Visa Inc. capital raising by deal type (2014-YTD2018)
Figure 9: Visa Inc. divestments volume and value trend (2014-YTD2018)
Figure 10: Visa Inc. divestments by geography (2014-YTD2018)
Figure 11: Visa Inc. private equity and ownership volume and value trend (2014-YTD2018)
Figure 12: Visa Inc. private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Visa Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Renco Group SpA:企業の戦略的SWOT分析
    Renco Group SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Drax Group Plc (DRX)-エネルギー分野:企業M&A・提携分析
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …
  • ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Citation Oil & Gas Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Citation Oil & Gas Corp (Citation) is an oil and gas exploration company that acquires, produces, and develops oil and gas properties. The company's products include natural gas, NGL, crude oil, and coalbed methane gas. It conducts asset development program for production and recoverable res …
  • Nascent Biotech Inc (NBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies and antigens for commercialization. It develops Pritumumab, a mono …
  • Pets at Home Limited (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Limited (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hotel Properties Limited:戦略・SWOT・企業財務分析
    Hotel Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Advance Syntex Limited:企業の戦略的SWOT分析
    Advance Syntex Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Prestige Brands Holdings Inc (PBH):企業の財務・戦略的SWOT分析
    Prestige Brands Holdings Inc (PBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Montefiore Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Montefiore Medical Center (MMC) is a healthcare service provider that offers clinical services. The center offers services such as allergy and immunology, orthopaedics, dentistry and oral surgery, dermatology, endocrinology, digestive and liver diseases, neurological surgery, otorhinolaryngo …
  • Constellation Brands Inc (STZ):企業の財務・戦略的SWOT分析
    Constellation Brands Inc (STZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tennessee Valley Authority:電力:M&Aディール及び事業提携情報
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers, local power companies and distributors. The agency generates power using diverse sources of energy such as hydro, nuclear, coal, diesel generator and other renewable based power plants. TVA p …
  • Blueprint Medicines Corp (BPMC):医療機器:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Accent Group Ltd (AX1):企業の財務・戦略的SWOT分析
    Accent Group Ltd (AX1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Qatar Petroleum:企業の戦略的SWOT分析
    Qatar Petroleum - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Catalyst Biosciences Inc (CBIO):医療機器:M&Aディール及び事業提携情報
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …
  • University Hospitals-製薬・医療分野:企業M&A・提携分析
    Summary University Hospitals is a healthcare service provider that offers patient-centered medical care and education services. The center includes network of specialty care physicians, skilled nursing, elder health, rehabilitation and home care services, managed care and insurance programs, occupat …
  • TAP Biosystems Ltd-製薬・医療分野:企業M&A・提携分析
    Summary TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a medical laboratory that provides laboratory and pharmaceutical equipment. The laboratory offers products such as single-use mini bioreactor systems and automated cell culture systems. It also provides labware, consu …
  • Pharma Mar SA (PHM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Cell Therapy Catapult Ltd-医療機器分野:企業M&A・提携分析
    Summary Cell Therapy Catapult Ltd (Catapult) is a developer of cell and gene therapies. The company supports cell and gene therapy companies worldwide to translate early stage research into commercially sustainable and investable treatments. It offers non-clinical safety, clinical trials, regulation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆